TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors
Adoptive T-cell therapies tailored for the treatment of solid tumors encounter intricate challenges, necessitating the meticulous selection of specific target antigens and the engineering of highly specific T-cell receptors (TCRs). This study delves into the cytotoxicity and functional characteristi...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2023-10-01
|
| Sarja: | Biomedicines |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2227-9059/11/10/2805 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
